Added to basket
Unapplied Changes
The British College of Aesthetic Medicine (BCAM) welcomes the Botulinum Toxin and Cosmetic Fillers (Children) Bill as a welcome step toward long-overdue tightening of regulation surrounding the accessibility of aesthetic interventions, particularly from non-medically qualified practitioners.
The Bill would create an offence for the administration of botulinum toxins or cosmetic fillers to people under 18 years of age unless there is an assessed medical need from a statutorily regulated healthcare professional. Recent data from BCAM’s annual audit reveals 43% of members polled have seen new patients presenting to them with complications following treatments by beauty therapists, the most popular patient treatment choices being botulinum toxin and dermal fillers.
Mr Greg White, Chief Executive of BCAM, says: “Let us be quite clear—patient safety is paramount. Dermal fillers in particular are plain dangerous in the wrong hands. Protecting vulnerable patients is not optional. Our survey yet again underlines the vital issue of agreeing a wider regulatory regime which supports controlled access to prescription medicines."
